Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Frankel AE, Woo JH, Ahn C. et al.
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

Blood 2014;
124 (03) 385-392

Bibliographische Angaben herunterladen

Aufrufen in: